Cloning and expression of human islet glutamic acid...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/60 (2006.01) A61K 38/51 (2006.01) A61M 1/38 (2006.01) C07H 21/00 (2006.01) C07K 16/40 (2006.01) C12N 1/19 (2006.01) C12N 5/10 (2006.01) C12N 9/88 (2006.01) C12Q 1/68 (2006.01) G01N 33/564 (2006.01) G01N 33/573 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2103159

2103159 9220811 PCTABS00017 Human pancreatic islet cell glutamic acid decarboxylase (GAD), an autoantigen involved in the development of insulin-dependent diabetes mellitus (IDDM), has been cloned, sequenced and expressed by recombinant means. Recombinant human islet cell GAD polypeptides and antibodies specific to the GAD polypeptides can be used in methods of diagnosis and treatment, including use in immunoadsorptive therapy and the induction of immune tolerance.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cloning and expression of human islet glutamic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cloning and expression of human islet glutamic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and expression of human islet glutamic acid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1917038

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.